Status:
COMPLETED
Vaginal Estrogen With Pessary Treatment
Lead Sponsor:
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Collaborating Sponsors:
Academic Medical Organization of Southwestern Ontario
University of Western Ontario, Canada
Conditions:
Vaginal Infection
Urinary Tract Infection
Eligibility:
FEMALE
18-100 years
Phase:
NA
Brief Summary
Patients presenting with pelvic organ prolapse will be offered the use of a pessary. Vaginal estrogen cream treatment with the pessary will be randomized amongst the patients and patient satisfaction ...
Detailed Description
This will be a double-blinded, placebo-controlled, randomized controlled trial. Eligible patients presenting to the urogynaecology clinic with pelvic organ prolapse will be offered management with a p...
Eligibility Criteria
Inclusion
- Any patient presenting to the clinic with pelvic organ prolapse will be offered management with a pessary and will be offered participation in the study.
Exclusion
- have a contraindication to the use of estrogen cream or products
- have any allergy to the use of estrogen cream or products
- have a past medical or family history of breast cancer
- have a past medical history of thromboembolism, myocardial infarction and stroke or are pregnant
- have previously used Premarin vaginal cream
- are currently using oral estrogen
- are not competent to consent
Key Trial Info
Start Date :
July 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2016
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT01843166
Start Date
July 1 2012
End Date
December 1 2016
Last Update
November 6 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
London Health Sciences Centre, University of Western Ontario
London, Ontario, Canada, N6A 5W9